SMTL ID : 9n9y.1

Crystal structure of truncated USP1:UAF1 in complex with compound 18

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 3.15 Å

Oligo State

hetero-1-1-mer

Ligands

1 x ZN: ZINC ION(Non-covalent)

ZN.1: 4 residues within 4Å: Chain B: C.169, C.172, C.235, C.238 4 PLIP interactions: 4 interactions with chain B Metal complexes: B:C.169, B:C.172, B:C.235, B:C.238

1 x 01: 2-(4-cyclopropyl-6-methoxypyrimidin-5-yl)-7-({4-[1-methyl-4-(trifluoromethyl)-1H-imidazol-2-yl]phenyl}methyl)-5H-pyrrolo[3,2-d]pyrimidine

01.2: 21 residues within 4Å: Chain B: N.10, L.13, Q.14, Y.17, F.18, L.69, V.73, L.76, Q.77, L.81, L.82, P.84, L.91, P.95, V.329, L.336, Y.339, L.344, F.346, S.349, V.351 13 PLIP interactions: 13 interactions with chain B Hydrophobic interactions: B:N.10, B:Q.14, B:L.69, B:L.76, B:Q.77, B:L.91, B:P.95 Hydrogen bonds: B:Q.14, B:Q.77, B:S.349, B:V.351 pi-Stacking: B:Y.339, B:F.346

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Throner, S. et al., Discovery of TNG-6132, a potent, selective, and orally bioavailable USP1 inhibitor. Bioorg.Med.Chem.Lett. (2025)

Release Date

2025-05-14

Peptides

WD repeat-containing protein 48: A
Ubiquitin carboxyl-terminal hydrolase 1, N-terminal fragment,Ubiquitin carboxyl-terminal hydrolase 1: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

WD repeat-containing protein 48

Ubiquitin carboxyl-terminal hydrolase 1, N-terminal fragment,Ubiquitin carboxyl-terminal hydrolase 1